Currently, Cabaletta Bio Inc [CABA] is trading at $4.91, up 1.13%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CABA shares have gain 16.51% over the last week, with a monthly amount glided 4.36%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cabaletta Bio Inc [NASDAQ: CABA] stock has seen the most recent analyst activity on October 10, 2024, when UBS initiated its Buy rating and assigned the stock a price target of $10. Previously, Jefferies started tracking the stock with Buy rating on February 05, 2024, and set its price target to $36. On November 29, 2023, William Blair initiated with a Outperform rating and assigned a price target of $38 on the stock. Cantor Fitzgerald started tracking the stock assigning a Overweight rating and suggested a price target of $40 on October 24, 2023. Stifel initiated its recommendation with a Buy and recommended $31 as its price target on October 19, 2023. Citigroup started tracking with a Buy rating for this stock on September 05, 2023, and assigned it a price target of $22. In a note dated July 18, 2023, Guggenheim initiated an Buy rating and provided a target price of $34 on this stock.
This stock has fluctuated between a low of $3.47 and a high of $26.35 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $16.33 within the next 12 months. Cabaletta Bio Inc [NASDAQ: CABA] shares were valued at $4.91 at the most recent close of the market. An investor can expect a potential return of 232.59% based on the average CABA price forecast.
Analyzing the CABA fundamentals
Gross Profit Margin for this corporation currently stands at 0.62% with Operating Profit Margin at -24.97%, Pretax Profit Margin comes in at -22.44%, and Net Profit Margin reading is -22.44%. To continue investigating profitability, this company’s Return on Assets is posted at -0.41, Equity is -0.44 and Total Capital is -0.5. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.74 points at the first support level, and at 4.57 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.01, and for the 2nd resistance point, it is at 5.11.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Cabaletta Bio Inc [NASDAQ:CABA] is 11.52. In addition, the Quick Ratio stands at 11.52 and the Cash Ratio stands at 9.98.
Transactions by insiders
Recent insider trading involved Binder Gwendolyn, that happened on Jan 19 ’24 when 11000.0 shares were sold., Binder Gwendolyn completed a deal on Dec 19 ’23 to sell 11000.0 shares. Meanwhile, Binder Gwendolyn sold 11000.0 shares on Nov 20 ’23.
